Literature DB >> 2647944

Viremia and neutralizing antibody response in infants with exanthem subitum.

Y Asano1, T Yoshikawa, S Suga, T Yazaki, T Hata, T Nagai, Y Kajita, T Ozaki, S Yoshida.   

Abstract

Mononuclear cell-associated viremia caused by human herpesvirus type 6 was detected in 39 (66%) of 59 blood samples from 38 children with exanthem subitum between day 0 and day 7 of the disease. The rate of virus isolation from mononuclear cells was 100% (26/26) on days 0 to 2 (just before appearance of skin rash), 82% (9/11) on day 3, 20% (2/10) on day 4, 7% (2/12) on days 5 to 7, and 0% (0/37) on day 8 and thereafter. The cell-free virus was detected in blood in 10 (21%) of 47 blood samples during the same period. The antibody activity to the virus, evaluated by a newly developed neutralization assay, was first detected on day 3 of the disease with a positive rate of 18% (2/11). It became 60% (6/10) on day 4, 75% (9/12) on days 5 to 7, and 100% on day 8 and thereafter. Thus the disappearance of the virus from blood was associated with the induction of specific immunity to the virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647944     DOI: 10.1016/s0022-3476(89)80689-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Infection and infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

3.  Clinical characteristics of febrile convulsions during primary HHV-6 infection.

Authors:  S Suga; K Suzuki; M Ihira; T Yoshikawa; Y Kajita; T Ozaki; K Iida; Y Saito; Y Asano
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

4.  Roseola infantum and human herpesvirus 6: old disease, new virus. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

Review 5.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 6.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

7.  Comparison of specific serological assays for diagnosing human herpesvirus 6 infection after liver transplantation.

Authors:  T Yoshikawa; J B Black; M Ihira; K Suzuki; S Suga; K Iida; Y Saito; K Asonuma; K Tanaka; Y Asano
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

8.  Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.

Authors:  J Wang; C Jones; M Norcross; E Bohnlein; A Razzaque
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection.

Authors:  Y Asano; T Yoshikawa; Y Kajita; R Ogura; S Suga; T Yazaki; T Nakashima; A Yamada; T Kurata
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

10.  Latent human herpesvirus-6 DNA is sparsely distributed in peripheral blood lymphocytes of healthy adults and patients with lymphocytic disorders.

Authors:  T Sandhoff; J P Kleim; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.